Print Page  |  Close Window

Investor Relations

At PRA Health Sciences, we work side-by-side with our clients, to move drug discovery forward, and to help them develop life-saving and life- improving drugs. For more than 30 years, we’ve been helping to bring to market everything from niche treatments and therapies to blockbuster drugs. Providing comprehensive Phase I-IV biopharmaceutical drug development in over 80 countries, we are dedicated to being innovative, and to delivering unmatched scientific expertise that improves the drug development process.

We help change people’s lives for the better every single day. It’s what we are passionate about.

Quote
NASDAQ GS: PRAH
$64.92Open: 64.45Day High: 65.04
Change(%): +0.81%Volume: 115,717Day Low: 63.90
Data Provided by Thomson Reuters Last Trade Time 03/29/17 2:29 p.m. ET